Peptide and protein pegylation II – clinical evaluation
Pharmacokinetic and biodistribution properties of poly(ethylene glycol)–protein conjugates
PEGylation of growth hormone-releasing hormone (GRF) analogues
Pegaspargase: a review of clinical studies
Pegvisomant in the treatment of acromegaly
Design of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) for chronic inflammatory diseases
Clinical development of PEGylated recombinant staphylokinase (PEG–Sak) for bolus thrombolytic treatment of patients with acute myocardial infarction